Henk-Jan Aanstoot was one of the founders of Diabeter in 2006, and is a member of the board of directors of the Diabeter Foundation. Current positions include physician (pediatric diabetology) at Diabeter, and consultant in pediatric diabetology at the IJsselland Ziekenhius, Capelle aan den IJssel, and at Erasmus MC, Rotterdam, The Netherlands. Previous positions include pediatrician at the Diabetes Clinic of the Sophia Children’s Hospital, Erasmus MC, Rotterdam, and member of the pediatric intensive care unit at the same cescientific board of the Dutch Diabetes Foundation, member of the steering committee of the International Study Group on Diabetes in Children, and member of the Diabetes Advisory Board of the Dutch Association of Pediatrics.

Dr Aanstoot’s current professional roles also include being chairman of the scientific board of the Dutch Diabetes Foundation, member of the steering committee of the International Study Group on Diabetes in Children, and member of the Diabetes Advisory Board of the Dutch Association of Pediatrics.

Research areas of interest include the improvement of clinical outcomes and quality of life in diabetes and other chronic diseases in children and adolescents, and the prediction and prevention of type 1 diabetes and its sequelae.

Selected important publications include:

• • Heyden JCV, Birnie E, Bovenberg SA, Dekker P, Veeze HJ1, Mul D, Aanstoot HJ. Losing Track of Lipids in Children and Adolescents with Type 1 Diabetes: Towards Individualized Patient Care. Exp Clin Endocrinol Diabetes. 2019 Jul 4. doi: 10.1055/a-0950-9677. [Epub ahead of print]

  • Aalders J, Hartman E, Nefs G, Nieuwesteeg A, Hendrieckx C, Aanstoot HJ, Winterdijk P, van Mil E, Speight J, Pouwer F. Mindfulness and fear of hypoglycaemia in parents of children with Type 1 diabetes: results from Diabetes MILES Youth – The Netherlands. Diabet Med. 2018 May;35(5):650-657.

  • Eilander MMA, Snoek FJ, Rotteveel J, Aanstoot HJ, Bakker-van Waarde WM, Houdijk ECAM, Nuboer R, Winterdijk P, de Wit M. Parental Diabetes Behaviors and Distress Are Related to Glycemic Control in Youth with Type 1 Diabetes: Longitudinal Data from the DINO Study. J Diabetes Res. 2017;2017:1462064.

  • Van der Heyden JC, Birnie E, Mul D, Bovenberg S, Veeze HJ, Aanstoot HJ. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study. BMC Endocr Disord. 2016 Sep 9;16(1):49.

  • Van der Heyden JC, Birnie E, Bovenberg SA, Cabezas MC, van der Meulen N, Mul D, Veeze HJ, Aanstoot HJ. Do traditional cardiovascular risk factors solely explain intima-media thickening in youth with type 1 diabetes? J Diabetes Complications. 2016 Aug;30(6):1137-43.

  • De Wit M, Winterdijk P, Aanstoot HJ, Anderson B, Danne T, Deeb L, Lange K, Nielsen AØ, Skovlund S, Peyrot M, Snoek F; DAWN Youth Advisory Board. Assessing diabetes-related quality of life of youth with type 1 diabetes in routine clinical care: the MIND Youth Questionnaire (MY-Q). Pediatr Diabetes. 2012 Dec;13(8):638-46

A complete bibliography can be found here.